 |
Sudipta
Basu
"Whoever could make two
ears of corn, or two blades of grass, to grow upon a spot
of ground where only one grew before, would deserve better
of mankind."
Jonathan Swift,
Gulliver's Travels (Voyage to Brobdingnag)
Any manager will tell you that
a company needs to plan quantum leaps in product, process
and profit to be on the growth path. But Dr M. S. Mithyantha,
vice president (R&D), Rallis Research Centre, puts his
company’s vocation in a nutshell, with this observation from
Jonathan Swift’s path breaking work.
To this end, and in order to stay ahead
of competition, Rallis India has celebrated many successes
and also derived many well-learnt lessons from its failures.
"We introduce at least two new products every year, apart
from concepts in marketing and production to stay on top of
the development curve," says Dr Mithyantha.
"Invention and exploitation is
innovation," he says. To get the formula right, innovative
marketing and problem solution practices are captured through
Innogate, an HR initiative, which in itself is innovative.
Over the last decade, the company has introduced a few landmark
products, ideas and concepts that have increased the profits,
just as it has learnt valuable lessons from a few not-so-successful
experiments.
People power
Rallis India devised Innogate, to encourage people to generate,
capture and implement new ideas in marketing and production.
The system aimed at inspiring the organisational community
to innovate, which in turn enhanced the organisation’s capability
of sharing knowledge and ensured proper recognition of idea
originators. The system operates in a networked environment
and is user-friendly. "In the last two years since its
implementation, a series of suggestions have been posted by
employees. These concepts are filtered through an Innogate
manager before presenting them to the board," says Mithyantha.
"These suggestions have affected cost reduction, improved
delivery systems and developed existing products."
The company, one of the agro majors
in the country, operates in a highly competitive market. Products
and operations are bound by statutory requirements of the
government. This necessitates evolving strategies to counter
the competition and also to comply with the regulations. The
various options include introducing new products regularly.
To meet this challenge, Rallis embarked on new product development
(NPD). The systematic introduction of the product with the
combined efforts of employees across the company enables cost
reduction and compression of time without compromising on
the quality of the product. The products identified are taken
through the conceptual 'innovation funnel,’ which critically
reviews the products to check various aspects such as market
potential, cost efficiency, techno-feasibility, bio-efficacy,
safety of the product to humans and the environment, etc.
"Innogate also acts as a bonding
exercise across the company. The essence of Innogate is capturing
and prioritising development of new products and services
to add value to the customer. By addressing the needs of the
customer, the practice enables creating satisfied and loyal
customers, which in turn helps the company in the market place,"
adds Mithyantha.
Some of the Innogate ideas, which have
been suggested and are under evaluation, are:
- Use of low-density oil (low-cost
fuel) instead of HSD in the incinerator leading to cost
saving in Patancheru factory
- Cost reduction by incorporating
spray quencher in the incinerator meant for effluent treatment
instead of the frequent changing over of gas cooler bundles
(to be implemented at Patancheru factory)
- Use of benzyl trimethyl ammonium
in organo-clay formulations of herbicides to enhance the
absorption of the non-polar herbicides by the organo-clay
complex and to reduce photodecomposition and volatilisation
of the herbicide
- New formulation delivery system
- Use of controlled release pesticide formulations, which
are environmentally friendly, to reduce overdosing of the
pesticide
- Sales improvement: Increasing sales
of Contaf in Tamil Nadu by educating farmers there about
its effect in paddy, thereby aiding in market expansion
Success stories
Rallis carried out successful product innovations, the important
ones being Hexaconazole and Imidacloprid. In 1987, the company
decided that it did not have a blockbuster compound. The reason
for this was that Rallis was considered a strong insecticide
company; and 80 per cent of the sale came from insecticides.
The company checked its usability mostly only on cotton and
rice. It now decided to expand its zone into fungicide.
Rallis undertook a research into the
total crop loss in the country due to fungus. It was found
that of the 40 million hectare used for cultivating wheat,
rice, apples and grapes, at least 15 million hectare is affected
by fungus. There was no effective control measure at that
time to combat the diseases, particularly to a class of fungal
disease called powdery mildew.
Hexaconazole, a fungicide, is used
against plant diseases. Its brand Contaf became the brand
leader when it hit the market in 1996. The compound was conceptualised
in 1988. Mithyantha states that for four years, 40 per cent
of the gross contribution has come from this product.
Contaf did not make a big headway in
Europe as it was used only on cereal crops such as wheat and
barley. In India, it was used on a wide range of crops such
as apple, coffee, tea, rice, fruits, vegetables and pulses,
because of its ability to control a wide range of diseases.
Due to the lack of a system of monopoly in the country, since
2002 a few other players have also introduced similar products
in the industry. This has not affected Rallis’ market share,
although the prices have crashed. The company continues to
make substantial profits from this product. "Today when
any product is introduced, we have the advantage of its newness
for a year, till the others catch up," says Mithyantha.
The company produced this at 60 per
cent of the earlier cost by the European producer. The product
was priced at Rs 450. Today it sells at Rs 300. "It was
important to attain a small volume but big value," says
Mithyantha.
The gestation period of any product
is long. Between 1988-96 the company generated data on the
chemistry of the compound, its biological performance in the
field and its effects on the environment. Every compound must
meet the RRRR control system — right method, right dose, right
time and the right chemical specifications of a compound.
The company seeks multi-seasonal and multi-locational information
about the product and tests its biological efficacy and its
environmental fate. In the process, the following questions
are answered: how toxic is the compound, how much chemical
is retained on the plant, can it be mixed with other compounds,
how does it get metabolised, will the chemical remain as a
parent compound, what happens to its efficacy when the compound
becomes degraded, etc. These experiments help in determining
the product’s level of toxicity, which results in arriving
at the maximum residue limit.
The product’s toxicity is tested on
animals. Sub-lethal doses are administered on rats over a
period of time and the changes monitored. Chronic toxicity
is also registered by feeding the animal through its lifespan
with very low doses of the compound, for two years. By the
end of this experiment, one comes up with a concept called
no observable adverse effect level (NOAEL). This also reveals
the product’s carcinogenic possibility and its effects on
an animal’s reproductive system through three generations.
Toxicity is tested on environmental
animals too: fish, honey bees and spiders. This provides a
holistic view of the product. According to NPD, the total
time for the experiment is 72 months. The company has spent
Rs 8 crore for this experiment. In 2000, the company grossed
Rs 40 crore from the product.
The second successful innovation, Imidacloprid,
is effective against sucking pests, found underneath the surface
of the leaf. It is used in very low doses. Rallis is the second
producer of the compound in the world. The product was first
sold in the market at Rs 3,800, till Rallis re-engineered
the product and sold it at Rs 2,400. Today, after three years,
it is available at Rs 1,500. The company had the cost advantage
for two years. The product was conceptualised in 1997. In
2001 it was introduced in the market and is being largely
used on cotton, rice and vegetables.
Not so successful innovation
Rallis’ foray into rodenticide with Bromadiolone, however,
proved unsuccessful. The company re-engineered the product
manufactured by a French company. The product in the form
of a cake, was used for killing rats: after a few days from
its consumption of the rodenticide, the rats die of internal
hemorrhage. Ultimately, the product turned out better than
the original French product. The original compound was sold
at Rs 1.13 lakh per kilo while Rallis’ cost was Rs 21,000.
However, Rallis was not in the household
business and the present NPD process was yet to be formulated.
The product could not impact the market. The company made
the product in small quantities and sold it to coconut farmers.
Today, Rallis has handed over the product’s marketing to Godrej.
"We have to critically examine the market. The product
may be good, but cannot work in isolation from market demands.
This was one of the mistakes that propelled the application
of the NPD within the company," says Mithyantha, of the
learning.
Unsuccessful innovation
Thiophante-methyl, a fungicide, was a failed enterprise by
Rallis. In 1990, the company used a fungicide called Captafol,
which was a suspected carcinogenic. Rallis was producing 400
metric tonnes of the product in a year. That is when the company
thought of a substitute called Thiophante-methyl. The compound
was inspired by a BASF product, Carbendazim. Thiophante-methyl
was a rung above Carbendazion, and was less expensive. But
it was no match for Captafol. The farmers rejected it.
Rallis derived an important learning
from this experiment. The company now understood importance
of product positioning. It was erroneous to position Thiophante-methyl
as a substitute to Captafol. "We learnt to work from
the field backwards," says Mithyantha. "The failure
was the result of a lack of marketing feedback to R&D.
Since this experiment, the marketing and R&D units began
working closely. Today a product is conceptualised and critically
examined by the marketing department before it is put on the
market development".
Accidental innovation
Sometimes it pays to break a rule. Fenitrothion, an insecticide,
is the finest example of that act. The product, originally
made and marketed by Sumitomo in Japan about two decades back,
is now obsolete. In 1974, Rallis created the solvent partnering
with Sumitomo. The company could manufacture the product only
to its 94-95 per cent purity. The international requirement
was 97 per cent. The prevalent practice was to crystalise
the solvent and wash it. A lab assistant washed the product
with solvent with alkali, and achieved the intended levels
of purity. Traditionally, the product is never washed with
alkali to avoid it from wearing down its properties.
"It escaped everyone that
the degradation with alkali takes place only in an aqueous
medium. This solvent was a non-aqueous medium. There was no
water concentration in it," says Mithyantha. "The
lab assistant was insightful enough to realise this and act
upon it." The assistant won accolades from colleagues
and seniors, and was awarded for his endeavour. Sumitomo marketed
the product till 1984. Eventually it was discontinued from
the market when similar products hit the shelves.
Other articles on innovation:
Other articles on Rallis India:
 |
Research
is the key
Successful companies
pay as much attention to the search for newer forms
of knowledge as to their application. Rallis has made
significant strides in research and development
|
Uploaded on November 4, 2004
|